Chairman, Asian Cellular Therapy Organization
Akihiro Shimosaka is the current President of the Asian Cellular Therapy Organization (ACTO). The ACTO is a non-profit organization that aims to promote research, development, and clinical application of cellular therapies in the Asian region. The organization also aims to establish ethical and safety standards for cellular therapy and promote collaborations among researchers and practitioners in the field.
As the President of ACTO, Akihiro Shimosaka is responsible for leading the organization and overseeing its activities. He is also involved in promoting research and collaboration in the field of cellular therapy in the Asian region.
Dehbashi et al., Front Oncol. 2021
Dehbashi et al., Biol Chem. 2020
Gunter et al., Cytotherapy. 2010
Harada et al., J Immunother. 2005
Hori et al., J Immunother. 2004
Shimosaka A et al., Int J Hematol. 2002
Lee JJ et al., Stem Cells. 2002
The First Affiliated Hospital, Zhejiang University School of Medicine
Zhejiang Society for Immunology
? Copyright Cell Research Symposium - All rights reserved.